ONCOSTELLAE
Oncostellae has been founded in 2013 by a group of researchers (chemists, biochemists and pharmacologists) who have a common track record in developing clinical drug candidates until phase II. Our objective is to discover and develop small molecule drugs for the treatment of cancer by generating pharmaceutical research programs around novel modulators of validated cancer targets like e.g. nuclear receptors and kinases. The company’s strategy includes running the discovery and development p... rocess with limited headcounts and focusing internal activities on project management, medicinal chemistry and in vitro pharmacology. The remaining activities of the R&D process like in vivo pharmacology, toxicology and clinical trials are subcontracted to qualified providers. The commercial goal is to license a clinical drug candidate including intellectual property and preclinical/clinical data package to a consolidated pharmaceutical or biotechnological company.
ONCOSTELLAE
Social Links:
Industry:
Health Diagnostics Medical Pharmaceutical
Founded:
2013-01-01
Address:
Orense, Galicia, Spain
Country:
Spain
Website Url:
http://www.oncostellae.com
Total Employee:
1+
Status:
Active
Contact:
34670008944
Email Addresses:
[email protected]
Total Funding:
1000 K USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Wordpress Plugins Sitelinks Search Box
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Scilex Pharmaceuticals
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Vetsource
Vetsource provides comprehensive solutions to those who care for pets - veterinarians and pet owners.
Current Advisors List
Current Employees Featured
Founder
Investors List
Official Site Inspections
http://www.oncostellae.com
- Host name: hw106.dinaserver.com
- IP address: 82.98.168.94
- Location: Spain
- Latitude: 40.4172
- Longitude: -3.684
- Timezone: Europe/Madrid
More informations about "Oncostellae"
About us - Oncostellae
Oncostellae is a clinical-stage biopharmaceutical company pioneering the discovery and development of proprietary drug candidates that address high unmet medical needs in …See details»
Oncostellae - Crunchbase Company Profile & Funding
Oncostellae may be growing as it has recently completed a funding round, securing an investment of 3.3 million euros from Bio & Tech Smart Capital. …See details»
Oncostellae - Cluster Transfronterizo Biotecnológico
Oncostellae Description The company was founded in 2013 by a team of pharmacists with a common track record in drug discovery, who bring together the expertise and network of collaborators needed to develop clinical …See details»
Oncostellae - LinkedIn
Oncostellae | 1,483 followers on LinkedIn. Novel small-molecule drugs in immunology, fibrosis and women health | Clinical-stage biotech company founded by serial entrepreneurs and …See details»
Oncostellae 2025 Company Profile: Valuation, Funding ... - PitchBook
Oncostellae General Information Description. Developer of molecule drugs designed to focus on the treatment of autoimmune diseases. The company's drugs are created with innovative …See details»
Oncostellae - Craft
Oncostellae has 5 employees at their 1 location and $1 m in total funding,. See insights on Oncostellae including office locations, competitors, revenue, financials, executives, …See details»
Oncostellae - VentureRadar
Find out more about Oncostellae, Biotechnology, drug discovery, Small-molecule drugs, clinical candidates, JAK inhibitors and and . All; Ranked; Organisation Names; Apps and Links. …See details»
Oncostellae — Inveready
Oncostellae, founded in 2013, develops small molecule drugs for cancer, managing internal research and development with a lean team. They outsource activities like in vivo …See details»
Oncostellae - Biotech startup
Oncostellae is a clinical-stage biopharmaceutical company pioneering the discovery and development of proprietary drug candidates that address high unmet medical needs in …See details»
Oncostellae | EuroQuity
Oncostellae SL is a privately owned, clinical-stage biopharmaceutical company focused on the discovery and development of proprietary drug candidates with strong IP and worldwide rights …See details»
Oncostellae SL - Drug pipelines, Patents, Clinical trials - Synapse
May 7, 2025 Explore Oncostellae SL with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, Disease Domain:Neoplasms, Immune System Diseases, Technology …See details»
Oncostellae - Parc Científic de Barcelona
Oncostellae is a clinical-stage biopharmaceutical company focused on the discovery and development of proprietary drug candidates with strong IP and worldwide rights targeting …See details»
Oncostellae - Contacts, Employees, Board Members, Advisors
Oncostellae focuses on the discovery of new pharmaceutically active compounds and their development, from its initial phaseSee details»
Oncostellae - Unirisco
Oncostellae is a biotech company specialized in the development of new drugs for the treatment of certain diseases in oncology and autoimmune diseases, such as prostate cancer, …See details»
Projects - Funding Oncostellae
Oncostellae is owned primarily by the founders and the institutional investors Inveready, Xesgalicia, Fitalent, Unirisco and Bio&Tech Smart Capital. Public funding. Oncostellae has …See details»
Oncostellae - Funding, Financials, Valuation & Investors
Oncostellae focuses on the discovery of new pharmaceutically active compounds and their development, from its initial phase. New. Resources. Advanced Search. ... How much funding …See details»
Pipeline - Oncostellae
Oncostellae S.L. use (our own and third-party) cookies for personalization and advertising purposes to create profiles based on your web browsing history, for example, to show you …See details»
Cristina Balagué - Chief Scientific Officer at Oncostellae - The Org
Oncostellae has been founded in 2013 by a group of researchers (chemists, biochemists and pharmacologists) who have a common track record in developing clinical drug candidates until …See details»
Oncostellae - Cluster Transfronterizo Biotecnológico
Oncostellae Descripción La empresa fue fundada en 2013 por un equipo de farmacéuticos con una trayectoria común en el descubrimiento de fármacos, y que aúnan la experiencia y la red …See details»
Oncostellae - Updates, News, Events, Signals & Triggers
Oncostellae focuses on the discovery of new pharmaceutically active compounds and their development, from its initial phase. New. Resources. Advanced Search. Start Free Trial . Talk …See details»